Not veterinary advice. A dog that can't stand or breathe easily needs a vet visit now, not a call.How we make money
Free dog check
Comparing peptides · for dogs

BPC-157 vs TB-500 for dogs: which is better?

Neither BPC-157 nor TB-500 can be called better for dogs. See what each is, what evidence exists, how they are sold, and why no fair comparison has a winner.

No
winner
The short answer

Neither can be called better. BPC-157 and TB-500 have never been compared in dogs, and neither has a clinical trial in dogs or FDA approval for animals. BPC-157 has two lab papers in healthy beagles, and we found no study giving TB-500 to dogs. Your dog's diagnosis matters far more.

BPC-157 and TB-500 side by side

Both are not officially tested in dogs and not FDA-approved for animals. This table shows the facts we could verify, and the gaps in the evidence are the main finding.

What we checkedBPC-157TB-500
What it isA lab-made chain of amino acids, studied in the lab since the 1990sA lab-made fragment based on part of thymosin beta-4, a protein the body makes
Sold forTendons, ligaments, joints, gut, recoveryTendons, ligaments, joints, wounds, recovery
Clinical trials in dogsNone in PubMed (checked 6 Nov 2026)None in PubMed (checked 6 Nov 2026)
Any dog dataTwo lab papers in healthy research beaglesWe found no study giving it to dogs
Tested in dogs with an injury or illness?NoNo
How it's sold for petsVials, capsules, oils, drops and treats, alone or in blendsVials, drops and treats, often in blends with BPC-157
FDA-approved for animals?NoNo
FDA safety concerns for human compoundingOn FDA's list: possible immune reactions, impuritiesOn FDA's list: possible clumping and impurities, no exposure data
Safe amount for a pet dogUnknownUnknown
Long-term safetyUnknownUnknown

Same answer for bothUnknown nobody has studied it

What each one is

BPC-157 is a short chain of amino acids. FDA has said that products sold under that name can differ, because multiple salts and derivatives have been sold under the same common name. A vial labelled BPC-157 may not hold the same thing as another vial with that label.

TB-500 needs a careful reading of the marketing. FDA's list calls it a fragment of thymosin beta-4. Some pages quote research on full thymosin beta-4, which is a larger, natural protein. A result for the whole protein may not apply to a fragment.

What evidence exists in dogs

For BPC-157, two papers include dogs. Xu 2020 reported that healthy research beagles tolerated repeated doses in a toxicity study. He 2022 measured how quickly beagles clear it. Neither tested sick pets, long-term use or products owners can buy, and neither shows that it treats anything.

For TB-500, our PubMed search of TB-500 and thymosin beta-4 in dogs turned up nothing where either was given to a dog. In other words, BPC-157 has a thin record in dogs and TB-500 has none we could find. Having a little safety data does not make BPC-157 more useful. It has still never been shown to do anything for a dog's injury.

Why there is no winner

A fair comparison needs both things tested in the same kind of dog, with the same problem, against a placebo. No such study exists. Any page that ranks one above the other is working from theory or seller claims.

You may read that one suits the gut and tendons and the other suits wider tissue repair. Those ideas come from lab work and marketing, and they haven't been tested in dogs. Picking one because it sounds like a better match would be a guess.

A real comparison also needs products you can trust. Products aren't checked by FDA, so the label may not match what's inside, and a vial from one seller may have little in common with a vial from another.

What about blends?

Blends of the two are common in pet sellers' products. They are sold on the idea that the two work together, and that has not been tested in dogs. A blend means two unknowns in one vial. If your dog has a reaction, nobody can say which ingredient caused it, and the amount of each is hard to check. Our seller comparison shows which sellers publish lab reports, and how to check a lab report explains what those reports can and can't prove.

What your vet would look at instead

Owners usually compare these two because their dog has a specific problem. Vets start by finding out exactly what is wrong, then use treatments with real evidence behind them. See a vet for any limp lasting more than a day, any weakness in the legs, or gut trouble lasting more than a day or two.

ProblemWhat vets usually doRead more
Torn ACLSurgery for most medium and large dogs, rehabBPC-157 and ACL tears
ArthritisApproved pain medicine, weight loss, rehabJoint pain guide
Back pain or weaknessUrgent exam, rest or surgeryIVDD guide
Long-running gut troubleTests and a diet trialGut guide
WoundsCleaning, antibiotics if infected, stopping the lickingWound guide

What to ask your vet

Bring the product page or label to the visit. If you can't get in quickly, a licensed online vet can help you think it through. For the bigger picture, read are peptides safe for dogs?

  • What exactly is wrong with my dog, and how sure are we?
  • What are the tested treatments, and which comes first?
  • Would this product clash with my dog's medicines or a planned surgery?
  • If I went ahead anyway, what would you want to monitor?
Talk to a licensed vet online

Dutch and Vetster connect you with a vet by video or chat. Ask how urgent it is, and whether anything you have read about makes sense. Start a vet chat

Questions dog owners ask

Is BPC-157 or TB-500 better for dogs?

Neither can be called better. They have never been compared in dogs, neither has a clinical trial in dogs, and neither is FDA-approved for animals. Your dog's diagnosis and your vet's tested options matter far more than this choice.

Can dogs take BPC-157 and TB-500 together?

Nobody knows if it is safe. The blend has not been tested in dogs, and a blend makes a reaction harder to trace. Nothing shows that the two work better together. Talk to your vet before giving either.

Is TB-500 the same as thymosin beta-4?

No. FDA lists TB-500 as a fragment of thymosin beta-4. The full protein is larger and occurs naturally in the body, so research on it may not apply to a fragment sold in a vial.

Has TB-500 been studied in dogs?

We found no published study that gave TB-500 or thymosin beta-4 to dogs (PubMed, checked 6 Nov 2026). That means its safety in dogs is unknown. BPC-157 has two lab papers in healthy research beagles, which is little more.

Which is safer for my dog, BPC-157 or TB-500?

Nobody can say. A toxicity study reported that healthy research beagles tolerated BPC-157, and there is no similar paper for TB-500. Neither has been tested in sick pets or over the long term, and the products themselves aren't checked by FDA.

Sources

  1. PubMed, BPC-157 in dogs, clinical trials only: no results, checked 6 Nov 2026. Open
  2. PubMed, TB-500 and thymosin beta-4 in dogs, clinical trials only: no results, checked 6 Nov 2026. Open
  3. Xu C et al. Preclinical safety evaluation of body protective compound-157. Regul Toxicol Pharmacol, 2020. Open
  4. He L et al. Pharmacokinetics, distribution, metabolism and excretion of BPC157, including in beagle dogs. Front Pharmacol, 2022. Open
  5. FDA, Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks (human compounding; page current as of 22 Apr 2026). Open
  6. FDA, Briefing Document, Pharmacy Compounding Advisory Committee, 23 to 24 Jul 2026 (BPC-157). Open
  7. FDA, Approved Animal Drug Products (Green Book): neither listed. Open